Origin Therapeutics Portfolio Company Tripsitter has Commenced Trading on the Canadian Securities Exchange
December 01, 2021 07:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, B.C, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”) an actively managed investment issuer focused on making equity...
Origin Therapeutics Announces Leadership Team
November 16, 2021 09:00 ET
|
Origin Therapeutics Holdings Inc.
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed investment issuer focused on making...
Origin Therapeutics Portfolio Company TripSitter Expands to Eight Additional States
November 05, 2021 12:00 ET
|
Origin Therapeutics Holdings Inc.
VANCOUVER, British Columbia, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”) an actively managed investment issuer focused on making...
Origin Therapeutics Files Preliminary Prospectus and Announces Initial Portfolio Companies
September 09, 2021 08:00 ET
|
Origin Therapeutics Holdings Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc....
Origin Therapeutics Closes $6.5 Million Private Placement to Fund New Investments in Psychedelics
August 12, 2021 08:00 ET
|
Origin Therapeutics Holdings Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:...
Origin Therapeutics Launches to Fund Emerging Psychedelics Companies
July 21, 2021 09:00 ET
|
Origin Therapeutics Holdings Inc.
VANCOUVER, British Columbia, July 21, 2021 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”), an actively managed investment issuer...